These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26917410)
41. Autophagy regulated by prolyl isomerase Pin1 and phospho-Ser-GSK3αβ involved in protection of oral squamous cell carcinoma against cadmium toxicity. So KY; Ahn SG; Oh SH Biochem Biophys Res Commun; 2015 Oct; 466(3):541-6. PubMed ID: 26381174 [TBL] [Abstract][Full Text] [Related]
42. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Girardini JE; Napoli M; Piazza S; Rustighi A; Marotta C; Radaelli E; Capaci V; Jordan L; Quinlan P; Thompson A; Mano M; Rosato A; Crook T; Scanziani E; Means AR; Lozano G; Schneider C; Del Sal G Cancer Cell; 2011 Jul; 20(1):79-91. PubMed ID: 21741598 [TBL] [Abstract][Full Text] [Related]
43. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide. Mathur R; Chandna S; N Kapoor P; S Dwarakanath B Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380 [TBL] [Abstract][Full Text] [Related]
44. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells. Yoon HE; Kim SA; Choi HS; Ahn MY; Yoon JH; Ahn SG Cancer Lett; 2012 Mar; 316(1):97-104. PubMed ID: 22115795 [TBL] [Abstract][Full Text] [Related]
46. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833 [TBL] [Abstract][Full Text] [Related]
47. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Mantovani F; Tocco F; Girardini J; Smith P; Gasco M; Lu X; Crook T; Del Sal G Nat Struct Mol Biol; 2007 Oct; 14(10):912-20. PubMed ID: 17906639 [TBL] [Abstract][Full Text] [Related]
48. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Miyashita H; Uchida T; Mori S; Echigo S; Motegi K Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768 [TBL] [Abstract][Full Text] [Related]
49. Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: possible implication of the Pin1 prolyl isomerase. Pushkarev VM; Starenki DV; Saenko VA; Pushkarev VV; Kovzun OI; Tronko MD; Popadiuk ID; Yamashita S Exp Oncol; 2008 Sep; 30(3):190-4. PubMed ID: 18806740 [TBL] [Abstract][Full Text] [Related]
50. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. Lim YS; Tran HT; Park SJ; Yim SA; Hwang SB J Virol; 2011 Sep; 85(17):8777-88. PubMed ID: 21680504 [TBL] [Abstract][Full Text] [Related]
51. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer. Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306 [TBL] [Abstract][Full Text] [Related]
53. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis. Endoh K; Nishi M; Ishiguro H; Uemura H; Miyagi Y; Aoki I; Hirano H; Kubota Y; Ryo A Prostate; 2012 May; 72(6):626-37. PubMed ID: 21809350 [TBL] [Abstract][Full Text] [Related]
54. Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells. Toko H; Hariharan N; Konstandin MH; Ormachea L; McGregor M; Gude NA; Sundararaman B; Joyo E; Joyo AY; Collins B; Din S; Mohsin S; Uchida T; Sussman MA J Biol Chem; 2014 Feb; 289(9):5348-56. PubMed ID: 24375406 [TBL] [Abstract][Full Text] [Related]
55. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. Wulf G; Garg P; Liou YC; Iglehart D; Lu KP EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284 [TBL] [Abstract][Full Text] [Related]
56. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins. Li M; Stukenberg PT; Brautigan DL Biochemistry; 2008 Jan; 47(1):292-300. PubMed ID: 18062707 [TBL] [Abstract][Full Text] [Related]
57. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. Stanya KJ; Liu Y; Means AR; Kao HY J Cell Biol; 2008 Oct; 183(1):49-61. PubMed ID: 18838553 [TBL] [Abstract][Full Text] [Related]
58. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation. Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597 [TBL] [Abstract][Full Text] [Related]
59. Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients. Chen J; Li L; Zhang Y; Yang H; Wei Y; Zhang L; Liu X; Yu L Biochem Biophys Res Commun; 2006 Mar; 341(4):1059-65. PubMed ID: 16476580 [TBL] [Abstract][Full Text] [Related]